News
1d
Capital Market on MSNBiocon arm gets USFDA approval for insulin, KirstyKirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to improve glycemic control in adults ...
Retail pharmacies could ramp up educational programs, rethink merchandising efforts and address product frustrations to make ...
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
Biocon Biologics has secured USFDA approval for Kirsty. Kirsty is an interchangeable biosimilar to NovoLog, used for diabetes ...
In 2019, Mattel released a Barbie in a wheelchair and a Barbie with a prosthetic limb. Other dolls in the Fashionistas line ...
The latest Barbie slays in a chic blue polka-dot crop top, ruffled miniskirt, chunky heels and an insulin pump. She is the ...
The US diabetes market presents a substantial opportunity for Biocon Biologics, with 38.4 million people living with diabetes ...
Mattel introduces a new Barbie doll representing Type 1 diabetes, complete with an insulin pump and glucose monitor, marking ...
Karnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received ...
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL) , a fully int ...
13d
New Scientist on MSN3D printing could enable a long-term treatment for type 1 diabetesSmall, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...
Engineers use sodium bicarb to “self-pressurize” a pill able to deliver drugs that usually require injection directly to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results